Abstract
Interferon regulatory factor-1 is an important transcription factor in the interferon system. We have demonstrated that the growth inhibitory effect of type 1 interferons on human hepatoma cells correlates with levels of transcription of the interferon regulatory factor-1 gene. In this study we investigated whether mutations in this gene cause different responses to type 1 interferons. DNA from several human hepatoma cell lines was investigated, and nucleotide sequences of the interferon regulatory factor-1 gene were determined. Several point mutations were detected in intron 8 of the gene, and one was found to cause deletion of BamHI cleavage sites. We found several point mutations in the upstream region of the interferon regulatory factor-1 exon 1, and the luciferase promoter assay demonstrated that these mutations modified its promoter activity. These results suggest that polymorphisms of the interferon regulatory factor-1 gene partially contribute to determining the response of cancer cells to growth inhibitory effect of type 1 interferons.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Yano H, Iemura A, Haramaki M, et al (1999) Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines. Hepatology 29:1708–1717
Tada S, Saito H, Tsunematsu S, et al (1998) Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-alpha in human hepatoma cell lines. Int J Oncol 13:1207–1216
Marth GT, Korf I, Yandell MD, et al (1999) A general approach to single-nucleotide polymorphism discovery. Nat Genet 23:452–456
Sims SH, Cha Y, Romine MF, et al (1993) A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol Cell Biol 13:690–702
Saito H, Tada S, Ebinuma H, et al (1996) Cloning of variable regions of an antibody that reacts with the soluble fraction of human liver cells and its possible value in chronic liver disease. Hepatology 23:1498–1506
Ebinuma H, Saito H, Saito Y, et al (1999) Antisense oligodeoxynucleotide against c-myc mRNA induces differentiation of human hepatocellular carcinoma cells. Int J Oncol 15:991–999
Shigematsu T, Miura S, Hirokawa M, et al (1998) Endothelins promote egg albumin-induced intestinal anaphylaxis in rats. Gastroenterology 115:348–356
Tanaka N, Ishihara M, Lamphier MS, et al (1996) Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382:816–818
Zeng YX, el-Deiry WS (1996) Regulation of p21 WAF1/CIP1 expression by p53-independent pathways. Oncogene 12:1557–1564
Saito H, Ebinuma H, Takahashi M, et al (1998) Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression. Hepatology 27:1233–1240
Coccia EM, Del Russo N, Stellacci E, et al (1999) Activation and repression of the 2–5A synthetase and p21 gene promoters by IRF-1 and IRF-2. Oncogene 18:2129–2137
Kadonaga JT, Jones KA, Tjian R (1986) Promoter-specific activation of RNA polymerase II transcription by Spl. Trends Biochem Sci 11:20–23
Baeuerle PA (1991) The inducible transcriptional activator NF-κB: regulation by distinct protein subunits. Biochim Biophys Acta 1072:63–80
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Japan
About this paper
Cite this paper
Saito, H. et al. (2001). Growth Inhibition of Hepatoma Cells by Type 1 Interferons: Modification by Mutations in the Interferon Regulatory Factor-1 Gene. In: Asakura, H., Aoyagi, Y., Nakazawa, S. (eds) Trends in Gastroenterology and Hepatology. Springer, Tokyo. https://doi.org/10.1007/978-4-431-67895-3_26
Download citation
DOI: https://doi.org/10.1007/978-4-431-67895-3_26
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-67993-6
Online ISBN: 978-4-431-67895-3
eBook Packages: Springer Book Archive